Results and evaluation of a first‐in‐human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|84|3|445-455

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.84, Iss.3, 2018-03, pp. : 445-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR study of mGlu5 inhibitors by genetic algorithm-multiple linear regressions

By Pourbasheer Eslam   Aalizadeh Reza   Ganjali Mohammad   Norouzi Parviz   Banaei Alireza  

Medicinal Chemistry Research, Vol. 23, Iss. 6, 2014-06 ,pp. : 3082-3091

Springer Publishing Company

Access to resources Recommend Favorite

A universal drug delivery catheter for the treatment of infrapopliteal arterial disease: Results from the multi‐center first‐in‐human study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 2, 2018-02 ,pp. : 296-301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 278-286

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐absence activity of mGlu1 and mGlu5 receptor enhancers and their interaction with a GABA reuptake inhibitor: Effect of local infusions in the somatosensory cortex and thalamus

By  

EPILEPSIA, Vol. 56, Iss. 7, 2015-07 ,pp. : 1141-1151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biphasic modulation of TRPV1 by mGluR5

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 4, 2015-02 ,pp. : 1020-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite